Loading...
XNAS
TRNS
Market cap703mUSD
Sep 19, Last price  
75.45USD
1D
-0.38%
1Q
-6.32%
Jan 2017
598.61%
Name

Transcat Inc

Chart & Performance

D1W1MN
No data to show
P/E
48.44
P/S
2.53
EPS
1.56
Div Yield, %
Shrs. gr., 5y
4.33%
Rev. gr., 5y
9.97%
Revenues
278m
+7.30%
60,471,00066,473,00070,453,00075,419,00081,061,00091,186,000110,020,000112,296,000118,508,000123,624,000122,166,000143,898,000155,141,000160,898,000173,099,000173,335,000204,959,000230,569,000259,481,000278,421,000
Net income
15m
+6.36%
3,577,0002,059,0002,363,0001,556,0001,451,0002,788,0003,302,0003,704,0003,984,0004,026,0004,124,0004,522,0005,922,0007,145,0008,067,0007,791,00011,380,00010,688,00013,647,00014,515,000
CFO
39m
+19.53%
4,435,0002,645,0003,593,0003,816,0005,649,0002,573,0006,259,0005,241,0007,612,0004,439,00010,982,0007,544,0009,874,00012,561,00011,561,00023,639,00017,618,00016,951,00032,616,00038,985,000

Profile

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
IPO date
Jul 05, 1965
Employees
1,030
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
278,421
7.30%
259,481
12.54%
230,569
12.50%
Cost of revenue
260,547
239,700
214,321
Unusual Expense (Income)
NOPBT
17,874
19,781
16,248
NOPBT Margin
6.42%
7.62%
7.05%
Operating Taxes
3,811
4,792
2,799
Tax Rate
21.32%
24.23%
17.23%
NOPAT
14,063
14,989
13,449
Net income
14,515
6.36%
13,647
27.69%
10,688
-6.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,691)
72,360
211
BB yield
0.25%
-7.78%
-0.03%
Debt
Debt current
5,440
4,849
2,248
Long-term debt
77,306
34,073
72,789
Deferred revenue
Other long-term liabilities
2,752
2,903
1,434
Net debt
81,229
3,643
73,306
Cash flow
Cash from operating activities
38,985
32,616
16,951
CAPEX
(13,197)
(13,280)
(9,414)
Cash from investing activities
(84,000)
(41,672)
(18,513)
Cash from financing activities
26,862
27,399
876
FCF
(8,833)
(1,095)
(265)
Balance
Cash
1,517
35,179
1,531
Long term investments
100
200
Excess cash
22,305
Stockholders' equity
95,713
83,545
71,744
Invested Capital
347,359
227,306
162,405
ROIC
4.89%
7.69%
8.74%
ROCE
5.01%
7.64%
9.62%
EV
Common stock shares outstanding
9,254
8,352
7,645
Price
73.38
-34.15%
111.43
28.39%
86.79
16.95%
Market cap
679,059
-27.04%
930,663
40.26%
663,510
17.81%
EV
760,288
934,306
736,816
EBITDA
36,441
33,325
27,203
EV/EBITDA
20.86
28.04
27.09
Interest
798
1,835
2,761
Interest/NOPBT
4.46%
9.28%
16.99%